MORTALITY PREVENTION IN SEPTIC MICE WITH MULTIPLE ORGAN DYSFUNCTION SYNDROME: THE OPTIMAL DOSE OF INTRAPERITONEAL HEAT SHOCK PROTEIN 70
DOI:
https://doi.org/10.22159/ajpcr.2018.v11i11.27773Keywords:
Lipopolysaccharide, Heat shock protein, Multiple organ dysfunction syndrome, DoseAbstract
Objective: Heat shock protein 70 (HSP70) reduces the expression of cytochrome C, B-cell lymphoma-associated X, and cysteine-aspartic acid protease 3 (Caspase 3), in apoptosis of multiple organ dysfunction syndrome (MODS), and thereby can prevent death. Previous researchers used 226 mg/kgBW/intraperitoneal (ip) of HSP70. This study aimed to determine the lowest effective dose of HSP70 to prevent death in sepsis mice model with MODS.
Methods: This was a randomized control trial conducted at Pusat Antar Universitas (PAU), Gadjah Mada University, Yogyakarta, Indonesia, from April 1, 2017 to April 21, 2017. The study subjects were Balb/c strain mice. The drug used to induce death was lipopolysaccharides (LPS). The drug used to prevent death in this study was Rat HSP70. A sample of 25 mice was randomized into five groups with each consisting of five mice: (1) Control group with NaCl, (2) experimental group receiving LPS injection of 0.25 mg/kgBW/i.p, (3) experimental group receiving the same dose of LPS injection with HSP70 injection of 100 μg/kgBW/ip, (4) experimental group receiving the same dose of LPS injection with HSP70 injection of 200 μg/kgBW/ip, and (5) experimental group receiving the same dose of LPS injection with HSP70 injection of 300 μg/kgBW/ip. Percentage of live mice between groups was compared by Chi-square test.
Results: 3 days after intervention, 13 (86.7%) live mice in the experimental group with ≥100 μg/kgBW/i.p HSP70 were >2 (40%) live mice in the experimental group with <100 μg/kgBW/i.p HSP70, with p=0.038. All mice receiving ≥200 μg/kgBW/ip HSP70 in the experimental group were Alive 3 days after intervention.
Conclusion: The lowest effective dose of HSP70 to prevent death in sepsis mice model with MODS is 200 μg/kgBW/ip. All mice are alive 3 days after receiving ≥200 μg/kgBW/ip HSP70.
Â
Downloads
References
Guntur HA. Sirs, Sepsis and Syok Septik. Imunologi, Diagnosis Penatalaksanaan. Cetakan 1, Surakarta: UNS Press; 2008. p. 37-48.
Singer M. The role of mitochondrial dysfunction in sepsis-induced multi-organ failure. Virulence 2014;5:66-72.
Babu M, Menon VP, Devi U. Epidemiology and outcome among severe sepsis and septic shock patients in a South Indian tertiary care hospital. Int J Pharm Pharm Sci 2017;9:256-9.
Marshall JC. Multiple organ dysfunction syndrome (MODS). In: Vincent JL, Sibbald WJ, ediotrs. Clinical Trials for the Treatment of Sepsis. Update in Intensive Care and Emergency Medicine. Vol. 19 Berlin, Heidelberg: Springer; 1999.
Joly AL, Wettstein G, Mignot G, Ghiringhelli F, Garrido C. Dual role of heat shock proteins as regulators of apoptosis and innate immunity. J Innate Immun 2010;2:238-47.
Sabirzhanov B, Stoica BA, Hanscom M, Piao CS, Faden AI. Over-expression of HSP70 attenuates caspase-dependent and caspase-independent pathways and inhibits neuronal apoptosis. J Neurochem 2012;123:542-54.
Aschkenasy G, Bromberg Z, Raj N, Deutschman CS, Weiss YG. Enhanced hsp70 expression protects against acute lung injury by modulating apoptotic pathways. PLoS One 2011;6:e26956.
Foroutan B, Razavianzadeh N, Anderson D. Overcoming chemoresistance in non-Hodgkin lymphoma preliminary studies of apoptosis and necrosis by P-Glycoprotein reversal agents. Int J Pharm Pharm Sci 2015;7:382-8.
Masterton RG. Antibiotic de-escalation. Crit Care Clin 2011;27:149 62.
Budi S, Ikawati Z, Dwiprahasto I, Nuryastuti T. Antibiotics administration to enhance the success of therapy in sepsis patients. Asian J Pharm Clin Res, Special issue 2017.
Santer R. Cellular mechanisms of aging. In: Fillit HM, Rockwood K, Woodhouse K, edtiors. Brocklehurst’s Textbook of Geriatric Medicine and Gerontology. 7th ed. Philadelphia, PA: Saunders/Elsevier; 2010.
Choudhury S, Bae S, Ke Q, Lee JY, Kim J, Kang PM, et al. Mitochondria to nucleus translocation of AIF in mice lacking hsp70 during ischemia/reperfusion. Basic Res Cardiol 2011;106:397-407.
Kustanova GA, Murashev AN, Karpov VL, Margulis BA, Guzhova IV, Prokhorenko IR, et al. Exogenous heat shock protein 70 mediates sepsis manifestations and decreases the mortality rate in rats. Cell Stress Chaperones 2006;11:276-86.
Evans CG, Chang L, Gestwicki JE. Heat shock protein 70 (hsp70) as an emerging drug target. J Med Chem 2010;53:4585-602.
Lee HJ, Ock CY, Kim SJ, Hahm KB. Heat shock protein: Hard worker or bad offender for gastric diseases. Int J Proteomics 2010;2010:11.
Green DR. Means to an End: Apoptosis and Other Cell Death Mechanisms. Cold Spring Harbor Laboratory Press. 2011. ISBN: 978-0-879698-87-4.
Kalogeris T, Baines CP, Krenz M, Korthuis RJ. Cell biology of ischemia/reperfusion injury. Int Rev Cell Mol Biol 2012;298:229-317.
Martinvalet D, Zhu P, Lieberman J. Granzyme A induces caspase-independent mitochondrial damage, a required first step for apoptosis. Immunity 2005;22:355-70.
Elmore S. Apoptosis: A review of programmed cell death. Toxicol Pathol 2007;35:495-516.
Van Amersfoort ES, Van Berkel TJ, Kuiper J. Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin Microbiol Rev 2003;16:379-414.
Galley HF. Bench-to-bedside review: Targeting antioxidants to mitochondria in sepsis. Crit Care 2010;14:230.
Xu JT, Vanderlick K, Beales PA. Lytic and non-lytic permeabilization of kardiolipin-containing lipid bilayers induced by cytochrome c. PLoS One 2013;8:e69492.
Brunelle JK, Letai A. Control of mitochondrial apoptosis by the bcl-2 family. J Cell Sci 2009;122:437-41.
Jiang X, Jiang H, Shen Z, Wang X. Activation of mitochondrial protease OMA1 by bax and bak promotes cytochrome c release during apoptosis. Proc Natl Acad Sci U S A 2014;111:14782-7.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
